NCT00937937

Dinaciclib in Treating Patients With Stage IV Melanoma

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2009-07-01Est. Completion: 2013-10-22

Enrollment target: 72 participants

Locations

Providence Hospital, Mobile, Alabama, United States
Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Highlands Oncology Group - Rogers, Rogers, Arkansas, United States
East Bay Radiation Oncology Center, Castro Valley, California, United States
Eden Hospital Medical Center, Castro Valley, California, United States
Valley Medical Oncology Consultants-Castro Valley, Castro Valley, California, United States
Bay Area Breast Surgeons Inc, Emeryville, California, United States
Valley Medical Oncology Consultants-Fremont, Fremont, California, United States
Contra Costa Regional Medical Center, Martinez, California, United States
El Camino Hospital, Mountain View, California, United States
Wilma Chan Highland Hospital, Oakland, California, United States
Alta Bates Summit Medical Center - Summit Campus, Oakland, California, United States
Bay Area Tumor Institute, Oakland, California, United States
Hematology and Oncology Associates-Oakland, Oakland, California, United States

Acral Lentiginous MelanomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Mucosal Melanoma

This phase II trial studies how pembrolizumab works before and after surgery in treating patients with stage III-IV high…

Birmingham, United StatesEst. completion Sep 1, 2022

SarcomaMerkel Cell Carcinoma

This study will test the safety of a study drug called CRD3874-SI. The researchers will test different doses of CRD3874-…

Basking Ridge, United States

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.